Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review)-Reference-Cited by-同舟云学术

Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review)

Published:2019-01-10 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Venanzi Rullo Emmanuele¹,Ceccarelli Manuela¹,Condorelli Fabrizio²,Facciol� Alessio¹,Visalli Giuseppa³,D'Aleo Francesco¹,Paolucci Ivana¹,Cacopardo Bruno⁴,Pinzone Marilia⁵,Di Rosa Michele⁶,Nunnari Giuseppe¹,Pellican� Giovanni⁷

Affiliation:

1. Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Messina, I-90124 Messina, Italy

2. Department of Pharmacological Sciences, University of Eastern Piedmont ‘A. Avogadro’, I-13100 Novara, Italy

3. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, I-90124 Messina, Italy

4. Department of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy

5. Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

6. Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, University of Catania, I-95123 Catania, Italy

7. Department of Human Pathology of the Adult and the Developmental Age ‘G. Barresi’, Unit of Infectious Diseases, University of Messina, I-98122 Messina, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties;PLOS Pathogens;2024-08-15

2. Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive review;Reviews in Medical Virology;2024-03

3. Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update;Life Sciences;2024-01

4. Four decades of continuing innovations in the development of antiretroviral therapy for HIV/AIDS: Progress to date and future challenges;Global Health & Medicine;2023-08-31

5. Hsa-circ-0000098 promotes the progression of hepatocellular carcinoma by regulation of miR-136-5p/MMP2 axis;Advances in Clinical and Experimental Medicine;2023-03-07